Cancer Stem Cells


  • Dito Anurogo Fakultas Kedokteran dan Ilmu Kesehatan, Universitas Muhammadiyah, Makassar, Indonesia



Cancer Stem Cells


This mini-review will discuss Cancer Stem Cells (CSCs) on their definition, history, characteristics, models, origin, tumorigenesis, targeting Cancer Stem Cells with nanomaterials, niche interactions, CSCs therapeutics, vaccination, the role of autophagy in CSCs, artificial intelligence, and clinical trials targeting CSCs.

Mini review ini membahas sel punca kanker (Cancer Stem Cells), meliputi: definisi, sejarah, karakteristik, model, asal-mula, tumorigenesis, menarget CSCs dengan nanomaterial, interaksi niche, terapeutik berbasis CSCs, vaksinasi, peran autofagi pada CSCs, kecerdasan buatan, dan uji klinik menarget CSCs.


Download data is not yet available.


Logtenberg ME, Boonstra J. Cancer stem cells and addicted cancer cells. Oncol Discov [Internet]. 2013;1(7). Available from: pdf/2052-6199-1-7.pdf

Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, Fazioli F, et al. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo. FASEB J. 2011;25(6):2022-30.

Papaccio F, Paino F, Regad T, Papaccio G, Desiderio V, Tirino V, et al. Concise review: cancer cells, cancer stem cells, and mesenchymal stem cells: Influence in cancer development. Stem Cells Translational Med. 2017; 6(12): 2115-25.

Sagar J, Chaib B, Sales K, Winslet M, Seifalian A. Role of stem cells in cancer therapy and cancer stem cells: A review. Cancer Cell Internat. 2007;7(1):9.

Atashzar MR, Baharlou R, Karami J, Abdollahi H, Rezaei R, Pourramezan F, et al. Cancer stem cells: A review from origin to therapeutic implications. J Cellular Physiol. 2020;235(2):790-803.

Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414(6859): 105-11.

Brunschwig A, Southam CM, Levin AG. Host resistance to cancer. Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes. Ann Surg.1965;162(3): 416.

Kleinsmith LJ, Pierce GB. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 1964;24(9):1544-51.

Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 2003;100(7):3983-8.

Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cellular Physiol. 2019;234(6): 8381-95.

Rahman M, Jamil HM, Akhtar N, Rahman KMT, Islam R, Asaduzzaman SM. Stem cell and cancer stem cell: A tale of two cells. Progress in Stem Cell. 2016; 3(02): 97-108.

Singh SP, Singh R, Gupta OP, Gupta S, Bhatt MLB. Immunotherapy: Newer therapeutic armamentarium against cancer stem cells. J Oncol. 2020;2020:3963561.

Zhu P, Fan Z. Cancer stem cells and tumorigenesis. Biophysics Rep. 2018;4(4):178-88.

Topcul M, Topcul F, Cetin I. Effects of femara and tamoxifen on proliferation of FM3A cells in culture. Asian Pac J Cancer Prev. 2013;14:2819-22.

Marusyk A, Polyak K. Tumor heterogeneity: Causes and consequences. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 2010;1805(1):105-17.

Melo FDSE, Vermeulen L, Fessler E, Medema JP. Cancer heterogeneity—a multifaceted view. EMBO rep. 2013;14(8): 686-95.

Knudson A, S. LC Heredity and cancer in man. 1973.

van Gastel N, Scadden DT. Young haematopoietic stem cells are picky eaters. Cell Res. 2021;31(4):377-8.

Sell S. On the stem cell origin of cancer. Am J Pathol. 2010;176(6): 2584-94.

Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006;355(12):1253-61.

Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K. Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Diseases 2015; 2(2): 152-63.

Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K. Emerging targets for glioblastoma stem cell therapy. J Biomed Res. 2016;30(1):19.

Walter RJ, Sonnentag SJ, Orian-Rousseau V, Munoz-Sagredo L. Plasticity in colorectal cancer: Why cancer cells differentiate. Cancers 2021;13(4): 918.

Arnold CR, Mangesius J, Skvortsova II, Ganswindt U. The role of cancer stem cells in radiation resistance. Front Oncol. 2020;10:164.

Safa AR. Oncogenomics. Cancer stem cells, apoptosis pathways and mechanisms of death resistance. Academic Press; 2019 .p. 89-101.

Zhou HM. Zhang JG, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: Mechanism, signaling, and prospective agents. Signal Transduction and Targeted Ther. 2021;6(1): 1-17.

French R, Pauklin S. Epigenetic regulation of cancer stem cell formation and maintenance. Internat J Cancer [Internet]. 2020. Available from: https://onlinelibrary.

Flavahan WA. Epigenetic plasticity, selection, and tumorigenesis. Biochem Soc Transact. 2020;48(4):1609-21.

Mittal P, Roberts CW. The SWI/SNF complex in cancer—biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020;17(7): 435-48.

Zhou M, Yuan J, Deng Y, Fan X, Shen J. Emerging role of SWI/SNF complex deficiency as a target of immune checkpoint blockade in human cancers. Oncogenesis 2021;10(1):1-8.

Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduction and Targeted Ther. 2020;5(1):1-35.

Hong IS, Jang GB, Lee HY, Nam JS. Targeting cancer stem cells by using the nanoparticles. Internat J Nanomed.2015;10(Spec Iss):251.

Duan H, Liu Y, Gao Z, Huang W. Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharmaceutica Sinica B 2021;11(1):55-70.

Lu B, Huang X, Mo J, Zhao W. Drug delivery using nanoparticles for cancer stem-like cell targeting. Front Pharmacol. 2016;7: 84.

Asghari F, Khademi R,Ranjbar FE, Malekshahi ZS, Majidi RF. Application of nanotechnology in targeting of cancer stem cells: A review. Internat J Stem Cells 2019;12(2): 227

Wang H, He X. Nanoparticles for targeted drug delivery to cancer stem cells and tumor. Methods Mol Biol. 2018;1831:59-67.




How to Cite

Anurogo, D. (2021). Cancer Stem Cells. Cermin Dunia Kedokteran, 48(11), 318–324.